[
    [
        {
            "time": "2021-10-01",
            "original_text": "U.S. COVID-19 deaths surpass 700K",
            "features": {
                "keywords": [
                    "COVID-19",
                    "deaths",
                    "surpass",
                    "700K"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 3,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "Merck's new COVID-19 pill 'not a replacement for the vaccine': Doctor",
            "features": {
                "keywords": [
                    "Merck",
                    "COVID-19",
                    "pill",
                    "vaccine"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "Why Merck's Covid Pill Is Shaking Vaccine Stocks Even As Boosters Launch",
            "features": {
                "keywords": [
                    "Merck",
                    "Covid",
                    "Pill",
                    "Vaccine",
                    "Boosters"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "Top Analyst Reports for Johnson & Johnson, Alibaba & Netflix",
            "features": {
                "keywords": [
                    "Analyst",
                    "Reports",
                    "Johnson & Johnson",
                    "Alibaba",
                    "Netflix"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "technology",
                    "entertainment"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 2,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "J&J to test experimental RSV vaccine in 23,000 people in Phase 3 clinical study",
            "features": {
                "keywords": [
                    "J&J",
                    "RSV",
                    "vaccine",
                    "Phase 3",
                    "clinical study"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "J&J reportedly seeks FDA approval of booster shot, William Shatner to blast into space, Oil spill closes CA beaches",
            "features": {
                "keywords": [
                    "J&J",
                    "FDA",
                    "approval",
                    "booster",
                    "shot"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "regulatory"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 4,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "JNJ, Xencor Sign $1.3B Licensing Deal For B-Cell Malignancies-Targeted Bispecific Antibody",
            "features": {
                "keywords": [
                    "JNJ",
                    "Xencor",
                    "Licensing",
                    "Deal",
                    "B-Cell",
                    "Malignancies",
                    "Bispecific",
                    "Antibody"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults",
            "features": {
                "keywords": [
                    "J&J",
                    "RSV",
                    "Vaccine",
                    "Efficacy",
                    "Older Adults"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "Johnson & Johnson Data on RSV Vaccines Raises the Bar in Industrywide Race",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "RSV",
                    "Vaccines",
                    "Industrywide",
                    "Race"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "Coronavirus tally: Global cases of COVID-19 near 235 million and J&J to seek FDA authorization for booster",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "Global",
                    "cases",
                    "COVID-19",
                    "J&J",
                    "FDA",
                    "authorization",
                    "booster"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "regulatory"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "UPDATE 2-J&J to seek U.S. FDA authorization of booster shot this week - NYT",
            "features": {
                "keywords": [
                    "J&J",
                    "FDA",
                    "authorization",
                    "booster",
                    "NYT"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "regulatory"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "Yahoo Finance's interview with Donald Trump",
            "features": {
                "keywords": [
                    "Yahoo Finance",
                    "interview",
                    "Donald Trump"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "politics",
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 1,
                "Entity_Density": 1,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 3,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-10-01",
            "original_text": "Johnson & Johnson Reportedly Set to Seek FDA OK for Covid Booster",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "FDA",
                    "OK",
                    "Covid",
                    "Booster"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "regulatory"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]